Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: J Trauma Acute Care Surg. 2022 Dec 14;94(3):484–489. doi: 10.1097/TA.0000000000003847

Timing of Venous Thromboembolism (VTE) Prophylaxis Initiation after Injury: Findings from the Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma

Morgan Schellenberg 1, Todd Costantini 2, Bellal Joseph 3, Michelle A Price 4, Andrew C Bernard 5, Elliott R Haut 6
PMCID: PMC9970012  NIHMSID: NIHMS1855589  PMID: 36729602

Abstract

Optimizing prophylaxis against venous thromboembolic events (VTE) is a critical issue in the care of injured patients. Although these patients are at significant risk of developing VTE, they also present competing concerns related to exacerbation of bleeding from existing injuries. Especially after high-risk trauma, including injuries to the abdominal solid organs, brain, and spine, trauma providers must delineate the time period in which VTE prophylaxis successfully reduces VTE rates without encouraging bleeding. Although existing data are primarily retrospective in nature and much further study is required, literature supports early VTE chemoprophylaxis initiation even for severely injured patients. Early initiation is most frequently defined as <48 hours from admission but varies from <24-72 hours and occasionally refers to time from initial trauma. Prior to chemical VTE prophylaxis initiation in patients at risk for bleeding, an observation period is necessary during which injuries must show themselves to be hemostatic, either clinically or radiographically. In the future, prospective examination of optimal timing of VTE prophylaxis is necessary. Further study of specific subsets of trauma patients will allow for development of effective VTE mitigation strategies based upon collective risks of VTE and hemorrhage progression.

Keywords: venous thromboembolism, trauma, optimal timing, chemoprophylaxis

Background

Venous thromboembolic events (VTE) occur frequently after trauma, particularly without prompt initiation of chemoprophylaxis12. Pharmacologic prophylaxis for VTE prevention is well accepted to prevent events and numerous national guidelines recommend its routine use in trauma patients37. Delineation of the optimal time to begin prophylaxis is critical to maximize reduction in VTE rates while avoiding bleeding complications. This is particularly true after injuries that present an ongoing hemorrhage risk (e.g. abdominal solid organ trauma) and/or those that occur within a small confined space, in which even small degrees of bleeding or hematoma expansion can have critical or catastrophic consequences, such as traumatic brain injuries (TBI) and spine injuries, including vertebral fractures and spinal cord injuries (SCI).

The competing needs to balance prompt initiatation of VTE chemoprophylaxis (VTEp) early while avoiding promotion of bleeding are incompletely adjudicated by existing literature. The optimal time to initiate VTEp, wherein prevention of VTE will be maximized while minimizing the risk of bleeding, is not yet defined in a nuanced way. Particularly for pateints with selected traumatic injury paterns, the empiric specification of the optimal timeframe within which to begin VTEp is critical to ensure optimal prevention of VTE without provocation of bleeding.

The objective of this manuscript is to summarize the current published literature on the topic of timing of pharmacologic prophylaxis initiation in trauma patients. We will also report on the knowledge gaps as noted at the recent Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma (https://www.nattrauma.org/research/research-policies-templates-guidelines/vte-conference/).

Solid Organ Injuries

Abdominal solid organ injuries (SOI) include the liver, kidneys, and spleen. Because of the frequency with which SOIs are managed nonoperatively, particularly after blunt trauma, the optimal time to initiate these patients on VTEp is a question commonly encountered by trauma providers. Historically, VTE prophylaxis was routinely held for patients with these injuries out of concern for the risk of recurrent bleeding. However, there is now a considerable body of literature, almost entirely retrospective, advocating for the safe and effective initiation of VTEp <48h of patient arrival to the emergency department (ED) with blunt SOI managed nonoperatively. There are no dedicated studies examining time of VTEp initiation on blunt SOIs managed operatively nor on patients with isolated penetrating SOI, regardless of management strategy. Further study of these specific populations is necessary to more completely understand the optimal time to begin VTEp after solid organ injury. At present, the literature on VTEp initiation after nonoperative blunt SOI is largely extrapolated to these other patient populations in clinical practice.

The existing literature on time to VTEp after blunt solid organ injury managed nonoperatively is comprised of one single-center prospective cohort study8, a small number of retrospective multicenter or database-driven cohort studies911, and several single-center retrospective studies1217. There are no prospective multicenter examinations of this subject, although an American Association for the Surgery of Trauma (AAST)-sponsored study with this design is currently in the data collection phase and will hopefully provide further evidence to inform patient care.

In addition to the published literature delineated above, this clinical and scientific question has triggered sufficient interest and study as to provoke several meta-analyses and systematic reviews1819. The take-home messages of this body of literature are clear. VTEp initiation <48h of emergency department arrival is associated with a reduction in VTE815 without an increase in failure of nonoperative management817,19 or need for blood transfusion8,1317,19. Key studies on the optimal time to VTEp initiation after solid organ injury are summarized in Table 1.

Table 1.

Key Studies on the Optimal Time to VTEp among Patients with Solid Organ Injury.

First Author Senior Author Journal Year Study Design Number of Patients Study Population Early VTEp Definition Important Findings - Early VTEp Is Associated with:
Joseph Rhee Am J Surg 2015 Retrospective Cohort n=116 Nonoperative blunt solid organ injuries ≤48h = Bleeding complications
= VTE
Khatsilouskaya Schnuriger World J Surg 2017 Retrospective Cohort n=179 Nonoperative blunt solid organ injuries <72h = Bleeding complications
= VTE
Murphy Vogt Can J Surg 2016 Retrospective Cohort n=162 Nonoperative blunt solid organ injuries <48h = Bleeding complications
= VTE
Schellenberg Demetriades World J Surg 2019 Prospective Cohort n=118 Nonoperative blunt solid organ injuries ≤48h = Bleeding complications
↓ DVT
= PE
Skarupa Joseph J Trauma Acute Care Surg 2019 Retrospective Cohort (TQIP) n=36,187 Nonoperative blunt solid organ injuries ≤48h = Bleeding complications
↓ DVT
↓ PE

VTEp, venous thromboembolism prophylaxis. VTE, venous thromboembolic events. DVT, deep vein thromboses. PE, pulmonary emboli. TQIP, Trauma Quality Improvement Program. =, comparable. ↓, reduced.

There are several notable limitations to existing studies. The first is that high grade (AAST grade ≥IV) solid organ injuries and combined solid organ injuries are underrepresented, potentially because these injuries are more likely to necessitate immediate operation. Therefore, the appropriateness of extrapolating existing data to high grade or combined solid organ injuries is unknown. Next, patients with associated TBI are excluded from approximately half of the published studies on the optimal time to initiate VTEp after blunt solid organ injury managed nonoperatively. The rationale for this exclusion is the fact that the presence of a concomitant TBI is likely to delay the initiation of prophylaxis. Moreover, TBIs are associated with coagulopathy and impact a patient’s risk of VTE. Therefore, further study is required to further elucidate the impact of an associated TBI on time to initiate prophylaxis and on resultant VTE risk after SOI.

Lastly, the collective interpretation of these studies is hindered by heterogeneity in outcomes definitions. For example, the definition of failure of nonoperative management varies amongst these studies as the need for either laparotomy or angioembolization (AE) at any time or at an interval of time after admission, ranging from >6-24 hours. To better amalgamate the literature and facilitate interstudy comparisons, we propose that failure of nonoperative management of blunt solid organ injury be defined as the need for exploratory laparotomy >6 hours after admission because this was the most common definition employed by related published studies19. Next, the inclusion of AE in the definition of failure of nonoperative management is problematic. AE has been touted as an important intervention by which to increase the rates of successful nonoperative management after blunt solid organ injury2022. It is confusing and counterintuitive, then, to use the need for AE as a barometer of failure of nonoperative management. Furthermore, delayed AE may be undertaken for pseudoaneurysm management after high grade solid organ injury, and not for bleeding control. Such patients have not failed nonoperative management and should not be coded as such. Finally, the definitions of early and late VTEp initiation vary across studies, with early groups defined by prophylaxis initiation anywhere from within 24-72 hours from admission but most commonly <48 hours. Because this is the most frequently utilized time cut-off, we propose that early prophylaxis administration be defined as initiation <48 hours of admission. This time frame also has a pathophysiologic correlate, with basic science studies supporting the transition of patients with SOI from a hypo- to a hypercoagulable state approximately 48 hours out from injury23. Since the publication of these studies, however, many trauma surgeons have become more aggressive about early initiation of VTEp and one wonders if <24 hours of admission may be a better target. Fundamentally, once a patient has demonstrated a lack of clinically relevant ongoing bleeding, VTEp should be promptly started as the focus shifts from hemorrhage mitigation to VTE prevention. As thromboelastography (TEG) is being more frequently utilized to trauma centers, perhaps initiation of prophylaxis based on TEG results may be an option to aid decision-making.

Moving forward in the examination of the optimal time to initiate VTEp after solid organ injury, we require further study of patients with high grade injuries; those with combined solid organ injuries and TBIs; patients with penetrating solid organ injuries; and more prospective data on the subject in general. In the interim, standardization of commonly used definitions in the study of these injuries would help literature cohesion.

Traumatic Brain Injuries (TBI)

Patients with TBI present particular concerns surrounding VTEp because provocation of bleeding within the intracranial space can have devastating consequences, even if the expansion in intracranial bleeding is small. Because of the fixed space within the cranial vault and the cerebral compression that can result from hematoma expansion, particularly in young patients, determining a safe window for timing of prophylaxis initiation is critical.

Unlike the literature on solid organ injuries and time to VTEp, the existing data on TBIs and optimal time for VTEp initiation are relatively sparse, particularly in terms of prospective data. This may be the result of persistent clinical equipoise. One prospective study demonstrated that among patients with low-risk TBI, defined by small-volume intracranial hemorrhage with demonstration of radiologic stability on computed tomography (CT) scan of the head at a 24-hour interval, VTEp could be safely initiated at 24 hours without any clinically relevant expansion of the intracranial bleeding24. These findings were echoed in a similar retrospective study published shortly thereafter, which showed that VTEp initiation 24 hours after stable CT Head was both effective and safe, i.e. reduced the rate of deep vein thromboses (DVT) without associated progression of intracranial hemorrhage25.

Based upon these studies and others, the American College of Surgeons (ACS) TQIP Best Practices in the Management of Traumatic Brain Injury guidelines advocate for VTEp initiation 24-72 hours after stable CT Head26. These guidelines are predicated on the intrinsic risk of intracranial hemorrhage expansion, as quantified by the Modified Berne-Norwood criteria. These criteria divide TBI patients into low, moderate, and high risk categories. High risk patients are those who have undergone neurosurgical intervention (craniotomy, craniectomy, and/or intracranial pressure monitor insertion) and/or have intracranial bleed progression on CT scan performed 72 hours after index scan26. High risk patients require an individualized approach due to lack of high quality evidence, with consideration of inferior vena caval filter placement. Moderate risk patients are those with epidural or subdural hematoma >8mm, intraventricular hemorrhage or contusion >2cm, multiple contusions/lobe, subarachnoid hemorrhage with abnormal CT angiography of the head, and/or intracranial bleed progression on CT scan at 24 hours26. These patients should have VTEp withheld until CT Head at 72h demonstrates radiographic stability. Patients without moderate and high risk features are deemed low risk and can be safely initiated on VTEp at 24 hours from stable CT Head26.

Safe VTEp initiation after severe TBI is challenging due to a paucity of data. A retrospective cohort study of TBI patients with GCS ≤8 and AIS Head ≥3 demonstrated that VTEp started <72h mitigated VTE risk without increasing mortality or the need for delayed neurosurgical intervention27. When TBI patients necessitating neurosurgical intervention (craniotomy/craniectomy or intracranial pressure monitor insertion) within 24 hours were specifically examined, the findings were less clear cut28. In this study, earlier VTEp initiation reduced VTE but increased risk of need for repeat neurosurgical intervention and even death in select subgroups. Overall, the authors advocate that VTEp <72h in patients with TBI who have undergone neurosurgical intervention may be ill advised. These disparate findings underline some of the challenges in the examination of this topic among TBI patients, with variables including intracranial intervention significantly impacting the safety of time to VTEp initiation. Key studies on the optimal time to VTEp initiation after TBI are summarized in Table 2.

Table 2.

Key Studies on the Optimal Time to VTEp among Patients with Traumatic Brain Injury.

First Author Senior Author Journal Year Study Design Number of Patients Study Population Early VTEp Definition Important Findings - Early VTEp Is Associated with:
Byrne Nathens J Am Coll Surg 2016 Retrospective Cohort n=3,634 TBI with Head AIS ≥3 and GCS ≤8 <72h ↓ DVT
↓ PE
= delayed neurosurgical intervention
= mortality
Byrne Seamon JAMA Surg 2022 Retrospective Cohort (TQIP) n=4,951 TBI with neurosurgical intervention <24h 24h periods* ↓ VTE
↑ delayed neurosurgical intervention
↑ mortality
Farooqui Litofsky J Neurosurg 2013 Retrospective Cohort n=236 TBI with ICH 24h after stable CTH ↓ DVT
= PE
= ICH progression
Phelan Minei J Trauma Acute Care Surg 2012 Randomized Controlled Trial n=62 Small TBI with stable CTH at 24h At 24h = VTE
= ICH progression
= mortality
*

instead of Early vs. Late groups, this study utilized 24-hour periods (days).

VTEp, venous thromboembolism prophylaxis. VTE, venous thromboembolic events. DVT, deep vein thromboses. PE, pulmonary emboli. TQIP, Trauma Quality Improvement Program. ICH, intracranial hemorrhage. =, comparable. ↓, reduced, ↑, increased.

Evidence is accumulating specifically among TBI patients that low molecular weight heparins (LMWH) may be superior to unfractionated heparin (UH) as a VTEp agent, providing a greater reduction in VTE rates2930. Furthermore, one study demonstrated improvement in in-hospital mortality rates when enoxaparin was used as the chemoprophylactic agent among patients with TBI as opposed to UH29. This clinical finding is supported by basic science work using rodent models, wherein LMWH imparted neuroprotective effects via reduction in cerebrovascular permeability and cerebral edema, with associated improved neurologic outcomes3132.

It is difficult to provide a simple, uniform recommendation about the optimal time to VTEp in patients with TBI as a result of the heterogeneous nature of this injury itself and the scarcity of existing literature. There is a clear potential for negative outcomes if VTEp is started overzealously early after TBI. Confirmation of radiographic stability via CT scan of the head appears to be an important component of the decision making. In general, VTEp initiation after TBI should occur at an interval of time, such as 48 hours, following stable CT Head and completion of intracranial intervention. Further study on this topic, particularly performed with a prospective multicenter design and with input of a broad multidisciplinary team, is urgently needed.

Spinal Cord Injuries (SCI)

Patients with SCI are well know to be at elevated risk for VTE. However, patients with spinal cord and column injuries are less well studied than patients with TBI in terms of the evidence surrounding optimization of VTEp initiation time. A systematic review published on the topic in 2011 included just five studies33, only one of which was specifically constructed to examine the optimal time at which to begin VTEp after spine injury34. Even major consensus guidelines generated by spine trauma surgeons are unable to suggest a safe window of time within which to initiate VTEp, recommending instead that VTEp simply be initiated “as soon as possible”35.

Based on the limited available literature, instituting VTEp <72h after SCI appears to be safe34,3637. Recent evidence suggests that even earlier VTEp initiation (<24-48h) may be safe and does not increase bleeding events3840. Even among patients with operatively managed spine trauma, VTEp initiation <48h appears to be safe in terms of bleeding risk and effective in terms of mitigating VTE4142. Existing studies are largely single-center retrospective endeavors and will necessitate validation with prospective multicenter evaluation. Key studies on the optimal time to VTEp initiation after spine injury are summarized in Table 3.

Table 3.

Key Studies on the Optimal Time to VTEp among Patients with Spine Injury.

First Author Senior Author Journal Year Study Design Number of Patients Study Population Early VTEp Definition Important Findings - Early VTEp Is Associated with:
Aito Cominelli Spinal Cord 2002 Prospective Cohort n=275 Traumatic SCI (ASIA A-D) <72h ↓ DVT
= PE
Chang Holcomb J Trauma Acute Care Surg 2011 Retrospective Cohort n=501 Traumatic SCI ≤48h ↓ DVT
= intraspinal hematoma expansion
Hamidi Joseph J Surg Res 2021 Retrospective Cohort n=526 Isolated operative traumatic spine fractures ≤48h ↓ DVT
= PE
= intraspinal hematoma expansion
Khan Joseph J Am Coll Surg 2018 Retrospective Cohort (TQIP) n=8,552 Nonoperative spine trauma <48h ↓ DVT
↓ PE
Kim Coimbra Spine 2015 Retrospective Cohort n=206 Operative traumatic spine fractures <48h = DVT
= PE
= neurologic progression

VTEp, venous thromboembolism prophylaxis. SCI, spinal cord injury. ASIA, American Spinal Injury Association impairment scale. DVT, deep vein thromboses. PE, pulmonary emboli. TQIP, Trauma Quality Improvement Program. =, comparable. ↓, reduced, ↑, increased.

The evidence surrounding VTEp agent selection for patients with SCI is also sparse, with one study demonstrating comparable VTE rates after SCI when prophylaxis was achieved with UH versus LMWH37. Conversely, others have shown improved VTE rates and lower or comparable risk of bleeding complications with the use of LMWH instead of UH for VTEp after SCI4344.

Part of the challenge in the rigorous scientific examination of this topic is the heterogeneity of these injuries. For example, patients with vertebral column fractures and no neurologic deficit are likely to differ in VTE risk from patients with true SCI due to degree of hindered mobility. The motor level and completeness of SCI may affect VTE risk as well. For instance, a patient with a complete SCI (i.e. ASIA A) SCI in the mid cervical cord will have a greater degree of immobility than a patient with similarly severe SCI in the distal thoracic spinal cord. These nuances may impart different degrees of VTE risk and therefore there may be subsets of spine-injured patients who require more or less aggressive approaches to early VTEp initiation. The ASIA classification is summarized in Supplemental Digital Content Table 145.

Moving forward, it will be important to delineate subsets of spine injury patients and an optimal approach to VTEp for each based upon the level and completeness of injury. Specifically, patients with vertebral fractures both with and without SCI need to be investigated and analyzed separately. The impact of spine injury level (cervical, thoracic, or lumbar) on VTE risk should also be examined to determine whether the optimal time to VTEp initiation should take motor injury level into consideration. Further subtleties will also need to be established, including the need for routine follow-up imaging to check for hematoma expansion after initiation of VTEp and/or the role for MRI in the diagnosis or exclusion of epidural hematoma prior to commencing VTEp.

Conclusions

In general for trauma patients with high-risk injuries including abdominal solid organs, TBI, and spinal cord/column, VTEp initiation can and should be pursued early after trauma once clinical and/or radiographic injury stability has been confirmed. Early VTEp commencement, typically <48h from time of admission or, in the case of TBI, from time of stable CT Head is safe and effective in the prevention of VTE. Further research, particularly prospective multicenter clinical trials, is needed to more completely delineate the optimal time for VTEp initiation after solid organ, TBI, and spine injuries46.

Supplementary Material

Supplemental Data File (.doc, .tif, pdf, etc.)

Supplemental Table 1. ASIA Spinal Cord Injury Impairment Scale.

ASIA, American Spinal Injury Association. SCI, spinal cord injury. From the American Spinal Injury Association International Standards for Neurological Classification of Spinal Cord Injury45.

Conflict of Interest

Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R13HL158206 (“Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma”). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author ERH reports research funding from The Patient-Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality (AHRQ), the NIH/NHLBI, and the DOD/Army Medical Research Acquisition Activity. Otherwise, the study authors have no conflicts of interest or disclosures of funding to declare.

Footnotes

Presentations

This study has not been presented at a meeting.

Social Media Summary

Optimal timing for initiation of pharmacologic VTE after high-risk injury remains controversial. Standardization should be encouraged to encourage optimal care for trauma patients.

#trauma #VTEprophylaxis #evidencebasedmedicine

@elliotthaut @NatTrauma @schellenbergMD

References

  • 1.Jacobs BN, Cain-Nielsen AH, Jakubus JL, Mikhail JN, Fath JJ, Regenbogen SE, et al. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma. J Trauma Acute Care Surg. 2017;83(1):151–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S–400S. [DOI] [PubMed] [Google Scholar]
  • 3.Yorkgitis BK, Berndtson AE, Cross A, Kennedy R, Kochuba MP, Tignanelli C, et al. American Association for the Surgery of Trauma/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma. J Trauma Acute Care Surg. 2022;92(3):597–604. [DOI] [PubMed] [Google Scholar]
  • 4.Ley EJ, Brown CVR, Moore EE, Sava JA, Peck K, Ciesla DJ, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: A Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2020;89(5):971–981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–3944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S–453S. [DOI] [PubMed] [Google Scholar]
  • 7.Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002;53(1):142–164. [DOI] [PubMed] [Google Scholar]
  • 8.Schellenberg M, Inaba K, Biswas S, Heindel P, Benjamin E, Strumwasser A, et al. When is it safe to start VTE prophylaxis after blunt solid organ injury? A prospective study from a level I trauma center. World J Surg. 2019;43(11):2797–2803. [DOI] [PubMed] [Google Scholar]
  • 9.Lin B, Matsushima K, De Leon L, Piccinini A, Recinos G, Love B, et al. Early Venous Thromboembolism Prophylaxis for Isolated High-Grade Blunt Splenic Injury. J Surg Res. 2019;243:340–345. [DOI] [PubMed] [Google Scholar]
  • 10.Skarupa D, Hanna K, Zeeshan M, Madbak F, Hamidi M, Haddadin Z, et al. Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision? J Trauma Acute Care Surg. 2019;87(5):1104–1112. [DOI] [PubMed] [Google Scholar]
  • 11.Rostas JW, Manley J, Gonzalez RP, Brevard SB, Ahmed N, Frotan MA, et al. The safety of low molecular-weight heparin after blunt liver and spleen injuries. Am J Surg. 2015;210(1):31–34. [DOI] [PubMed] [Google Scholar]
  • 12.Khatsilouskaya T, Haltmeier T, Cathomas M, Eberle B, Candinas D, Schnüriger B. Thromboembolic prophylaxis with heparin in patients with blunt solid organ injuries undergoing non-operative treatment. World J Surg. 2017;41(5):1193–1200. [DOI] [PubMed] [Google Scholar]
  • 13.Kwok AM, Davis JW, Dirks RC, Wolfe MM, Kaups KL. Time is now: venous thromboembolism prophylaxis in blunt splenic injury. Am J Surg. 2016;212(6):1231–1236. [DOI] [PubMed] [Google Scholar]
  • 14.Murphy PB, Sothilingam N, Charyk Stewart T, Batey B, Moffat B, Gray DK, et al. Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe. Can J Surg. 2016;59(2):118–122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Joseph B, Pandit V, Harrison C, Lubin D, Kulvatunyou N, Zangbar B, et al. Early thromboembolic prophylaxis in patients with blunt solid abdominal organ injuries undergoing nonoperative management: is it safe? Am J Surg. 2015;209(1):194–198. [DOI] [PubMed] [Google Scholar]
  • 16.Eberle BM, Schnüriger B, Inaba K, Cestero R, Kobayashi L, Barmparas G, et al. Thromboembolic prophylaxis with low-molecular-weight heparin in patients with blunt solid abdominal organ injuries undergoing nonoperative management: current practice and outcomes. J Trauma. 2011;70(1):141–146. [DOI] [PubMed] [Google Scholar]
  • 17.Alejandro KV, Acosta JA, Rodríguez PA. Bleeding manifestations after early use of low-molecular-weight heparins in blunt splenic injuries. Am Surg. 2003;69(11):1006–1009. [PubMed] [Google Scholar]
  • 18.Lamb T, Lenet T, Zahrai A, Shaw JR, McLarty R, Shorr R, et al. Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis. World J Emerg Surg. 2022; Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Murphy PB, de Moya M, Karam B, Menard L, Holder E, Inaba K, et al. Optimal Timing of Venous Thromboembolic Chemoprophylaxis Initiation following Blunt Solid Organ Injury: Meta-Analysis and Systematic Review. Eur J Trauma Emerg Surg. 2021; Epub ahead of print. [DOI] [PubMed] [Google Scholar]
  • 20.Miller PR, Chang MC, Hoth JJ, Mowery NT, Hildreth AN, Martin RS, et al. Prospective trial of angiography and embolization for all grade III to V blunt splenic injuries: nonoperative management success rate is significantly improved. J Am Coll Surg. 2014;218(4):644–648. [DOI] [PubMed] [Google Scholar]
  • 21.Smith HE, Biffl WL, Majercik SD, Jednacz J, Lambiase R, Cioffi WG. Splenic artery embolization: Have we gone too far? J Trauma. 2006;61(3):541–544; discussion 545–546. [DOI] [PubMed] [Google Scholar]
  • 22.Liu PP, Lee WC, Cheng YF, Hsieh PM, Hsieh YM, Tan BL, et al. Use of splenic artery embolization as an adjunct to nonsurgical management of blunt splenic injury. J Trauma. 2004;56(4):768–773. [DOI] [PubMed] [Google Scholar]
  • 23.Chapman BC, Moore EE, Barnett C, Stovall RT, Biffl WL, Burlew CC, et al. Hypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulation. Am J Surg. 2013;206:917–923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Phelan HA, Wolf SE, Norwood SH, Aldy K, Brakenridge SC, Eastman AL, et al. A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: The Delayed Versus Early Enoxaparin Prophylaxis I (DEEP I) study. J Trauma Acute Care Surg. 2012;73(6):1434–1441. [DOI] [PubMed] [Google Scholar]
  • 25.Farooqui A, Hiser B, Barnes SL, Litofsky NS. Safety and efficacy of early thromboembolism chemoprophylaxis after intracranial hemorrhage from traumatic brain injury. J Neurosurg. 2013;119(6):1576–1582. [DOI] [PubMed] [Google Scholar]
  • 26.Cryer HG, Manley GT, Adelson PD, Alali AS, Calland JF, Cipolle M, et al. American College of Surgeons Trauma Quality Improvement Program Guidelines, Traumatic Brain Injury. Committee on Trauma Expert Panel 1/2015, American College of Surgeons. 2015. [Google Scholar]
  • 27.Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, et al. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study. J Am Coll Surg. 2016;223(4):621–631. [DOI] [PubMed] [Google Scholar]
  • 28.Byrne JP, Witiw CD, Schuster JM, Pascual JL, Cannon JW, Martin ND, et al. Association of Venous Thromboembolism Prophylaxis After Neurosurgical Intervention for Traumatic Brain Injury With Thromboembolic Complications, Repeated Neurosurgery, and Mortality. JAMA Surg. 2022; Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Benjamin E, Recinos G, Aiolfi A, Inaba K, Demetriades D. Pharmacological Thromboembolic Prophylaxis in Traumatic Brain Injuries: Low Molecular Weight Heparin Is Superior to Unfractionated Heparin. Ann Surg. 2017;266(3):463–469. [DOI] [PubMed] [Google Scholar]
  • 30.Minshall CT, Eriksson EA, Leon SM, Doben AR, McKinzie BP, Fakhry SM. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2. J Trauma. 2011;71(2):396–9. [DOI] [PubMed] [Google Scholar]
  • 31.Li S, Marks JA, Eisenstadt R, Kumasaka K, Samadi D, Johnson VE, et al. Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo. J Trauma Acute Care Surg. 2015;79(1):78–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wahl F, Grosjean-Piot O, Bareyre F, Uzan A, Stutzmann JM. Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats. J Neurotrauma. 2000;17(11):1055–1065. [DOI] [PubMed] [Google Scholar]
  • 33.Christie S, Thibault-Halman G, Casha S. Acute pharmacological DVT prophylaxis after spinal cord injury. J Neurotrauma. 2011;28(8):1509–1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Aito S, Pieri A, D’Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord. 2002;40(6):300–303. [DOI] [PubMed] [Google Scholar]
  • 35.Ploumis A, Ponnappan RK, Bessey JT, Patel R, Vaccaro AR. Thromboprophylaxis in Spinal Trauma Surgery: Consensus among Spine Trauma Surgeons. Spine J. 2009;9(7):530–536. [DOI] [PubMed] [Google Scholar]
  • 36.Dhall SS, Hadley MN, Aarabi B, Gelb DE, Hurlbert RJ, Rozzelle CJ, et al. Deep Venous Thrombosis and Thromboembolism in Patients with Cervical Spinal Cord Injuries. Neurosurgery. 2013;72:244–254. [DOI] [PubMed] [Google Scholar]
  • 37.Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of Venous Thromboembolism in the Acute Treatment Phase after Spinal Cord Injury: A Randomized, Multicenter Trial Comparing Low-Dose Heparin Plus Intermittent Pneumatic Compression with Enoxaparin. J Trauma. 2003;54:1116–1126. [DOI] [PubMed] [Google Scholar]
  • 38.Khan M, Jehan F, O’Keeffe T, Hamidi M, Truitt M, Zeeshan M, et al. Optimal Timing of Initiation of Thromboprophylaxis after Nonoperative Blunt Spinal Trauma; A Propensity-Matched Analysis. J Am Coll Surg. 2018;226:760–768. [DOI] [PubMed] [Google Scholar]
  • 39.Chang R, Scerbo MH, Schmitt KM, Adams SD, Choi TJ, Wade CE, et al. Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury. J Trauma Acute Care Surg. 2017;83(6):1088–1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.DiGiorgio AM, Tsolinas R, Alazzeh M, Haefeli J, Talbott JF, Ferguson AR, et al. Safety and effectiveness of early chemical deep venous thrombosis prophylaxis after spinal cord injury: pilot prospective data. Neurosurg Focus. 2017;43(5):E21. [DOI] [PubMed] [Google Scholar]
  • 41.Hamidi M, Asmar S, Bible L, Hanna K, Castanon L, Avila M, et al. Early Thromboprophylaxis in Operative Spinal Trauma Does Not Increase Risk of Bleeding Complications. J Surg Res. 2021;258:119–124. [DOI] [PubMed] [Google Scholar]
  • 42.Kim DY, Kobayashi L, Chang D, Fortlage D, Coimbra R. Early pharmacological venous thromboembolism prophylaxis is safe after operative fixation of traumatic spine fractures. Spine. 2015;40(5):299–304. [DOI] [PubMed] [Google Scholar]
  • 43.Neifert SN, Chapman EK, Rothrock RJ, Gilligan J, Yuk F, McNeill IT, et al. Lower Mortality and Morbidity with Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis in Spine Trauma. Spine. 2020;45(23):1613–1618. [DOI] [PubMed] [Google Scholar]
  • 44.Green D, Chen D, Chmiel JS, Olsen NK, Berkowitz M, Novick A, et al. Prevention of thromboembolism in spinal cord injury: role of low molecular weight heparin. Arch Phys Med Rehabil. 1994;75(3):290–292. [DOI] [PubMed] [Google Scholar]
  • 45.American Spinal Injury Association (ASIA). International Standards for Neurological Classification of Spinal Cord Injury. 2019. Available at https://asia-spinalinjury.org/wp-content/uploads/2019/10/ASIA-ISCOS-Worksheet_10.2019_PRINT-Page-1-2.pdf [Accessed October 25, 2022].
  • 46.Haut ER, Byrne JP, Price MA, Bixby P, Bulger EM, Lake L, et al. Proceedings from the 2022 Consensus Conference to Implement Optimal Venous Thromboembolism (VTE) Prophylaxis in Trauma. J Trauma Acute Care Surg. 2022; Accepted. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data File (.doc, .tif, pdf, etc.)

Supplemental Table 1. ASIA Spinal Cord Injury Impairment Scale.

ASIA, American Spinal Injury Association. SCI, spinal cord injury. From the American Spinal Injury Association International Standards for Neurological Classification of Spinal Cord Injury45.

RESOURCES